A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by the age of 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.

PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...

Prostate cancer is the second leading cause of cancer deaths among men in the U.S. with more than 35,000 dying in 2025. It’s ...

SYRACUSE, N.Y. (WSYR-TV) — September is Prostate Cancer Awareness Month, and often there are no warning signs. That’s why ...

Newswise — PLYMOUTH MEETING, PA [April 28, 2026] — The National Comprehensive Cancer Network ® (NCCN ®)—an alliance of leading cancer centers—has published a new book explaining the latest evidence ...

Prostate cancer is the second most common cancer in US men. Guidelines for screening vary, underscoring the need to engage patients in shared decision-making and counsel them about potential benefits ...

Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...

The announcement Sunday that former President Joe Biden was diagnosed with advanced prostate cancer has some people wondering how the disease wasn’t spotted sooner. As president, Biden had access to ...